Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?
Clinical Research in Cardiology · 2026
DOI: 10.1007/s00392-024-02522-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Research in Cardiology, 2026. Verfasst von Ilaria Anna Bellofatto und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Genoa, 6 Viale Benedetto XV, 16132, Genoa, Italy. Hauptthemen laut MEDLINE: Amyloidosis, Inflammation, Cardiomyopathies, Myocardium. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca, Deutsche Forschungsgemeinschaft, European Cooperation in Science and Technology.
Abstract (Originalsprache)
The term cardiac amyloidosis (CA) refers to the accumulation of extracellular amyloid deposits in the heart because of different conditions often affecting multiple organs including brain, kidney and liver. Notably, cardiac involvement significantly impacts prognosis of amyloidosis, with cardiac biomarkers playing a pivotal role in prognostic stratification. Therapeutic management poses a challenge due to limited response to conventional heart failure therapies, necessitating targeted approaches aimed at preventing, halting or reversing amyloid deposition. Mechanisms underlying organ damage in CA are multifactorial, involving proteotoxicity, oxidative stress, and mechanical interference. While the role of inflammation in CA remains incompletely understood, emerging evidence suggests its potential contribution to disease progression as well as its utility as a therapeutic target. This review reports on the cardiac involvement in systemic amyloidosis, its prognostic role and how to assess it. Current and emerging therapies will be critically discussed underscoring the need for further efforts aiming at elucidating CA pathophysiology. The emerging evidence suggesting the contribution of inflammation to disease progression and its prognostic role will also be reviewed possibly offering insights into novel therapeutic avenues for CA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Genoa, 6 Viale Benedetto XV, 16132, Genoa, Italy.
- Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15771, Athens, Greece.
- Cardiology Unit, Ospedale Policlinico San Martino IRCCS, Genoa, Italy.
- IRCCS Ospedale Policlinico San Martino Genoa-Italian Cardiovascular Network, L.Go R. Benzi 10, 16132, Genoa, Italy.
- Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center "Guido Tarone", University of Torino, Turin, Italy.
- Institute for Pathophysiology, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany.
Förderung
- Ministero dell'Istruzione, dell'Università e della Ricerca
- Deutsche Forschungsgemeinschaft
- European Cooperation in Science and Technology
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Hellenic Foundation for Research and Innovation
- Università degli Studi di Genova
Zitieren
APA
Bellofatto, I. A., Nikolaou, P. E., Andreadou, I., Canepa, M., Carbone, F., Ghigo, A., Heusch, G., Kleinbongard, P., Maack, C., Podesser, B. K., Stamatelopoulos, K., Stellos, K., Vilahur, G., Montecucco, F., & Liberale, L. (2026). Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-024-02522-2
Vancouver
Bellofatto IA, Nikolaou PE, Andreadou I, Canepa M, Carbone F, Ghigo A, et al. Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?. Clinical Research in Cardiology. 2026. doi:10.1007/s00392-024-02522-2
BibTeX
@article{Bellofatto2026,
author = {Bellofatto, Ilaria Anna and Nikolaou, Panagiota Efstathia and Andreadou, Ioanna and Canepa, Marco and Carbone, Federico and Ghigo, Alessandra and Heusch, Gerd and Kleinbongard, Petra and Maack, Christoph and Podesser, Bruno K and Stamatelopoulos, Kimon and Stellos, Konstantinos and Vilahur, Gemma and Montecucco, Fabrizio and Liberale, Luca},
title = {Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?},
journal = {Clinical Research in Cardiology},
year = {2026},
doi = {10.1007/s00392-024-02522-2}
}
EUVIMED